Categories: News

82 Percent of Health Systems Reported Experiencing an IoT Cyberattack in Last 18 Months

BROOKLYN, N.Y., Nov. 16, 2021 /PRNewswire/ — Medigate, healthcare’s leading clinical device data security and integration platform, today announced it has launched a research collaboration with   CrowdStrike, a leader of cloud-delivered endpoint and workload protection. Titled “Healthcare IoT Security Operations Maturity — A Rationalized Approach to a New Normal,” the paper highlights recent cyberattack trends, including the increase in ransomware, and emphasizes the need for Healthcare Delivery Organizations (HDOs) to harden their security infrastructures via a renewed focus on defense fundamentals.

Cyberattacks surged during the pandemic. Multiple sources cited in the paper indicate that roughly eighty-two percent of health systems experienced some form of IoT cyberattack. Thirty-four percent of the reported attacks were ransomware. Thirty-three percent reported paying the ransom, but only sixty-nine percent of those that paid the ransom reported having their data fully restored. This paper explores the policy debate surrounding ransomware payments in a context that includes emerging cyber-insurance considerations and the fact that no standard for detailing attack restoration costs yet exists.

“Healthcare now understands the reality of the threat and is doing something about it. And that’s a good thing. But, when faced with all the advanced options promoting layered defense capabilities, we thought it was time to detail a more simplified approach,” said Jonathan Langer, Co-Founder and CEO of Medigate. “HDOs require a unified security approach to defend against evolving threat landscapes.”

The report covers various capabilities that health systems should consider in defending their organizations against advanced threats, including the integration benefits of the CrowdStrike Falcon® platform and Medigate platform as well as threat containment and well-scoped insurance coverage.

“As sophisticated threat activity continues to accelerate and the number of medical devices connecting to hospital networks increases, the healthcare industry continues to be a prime target for threat actors,” said Drex DeFord, Executive Healthcare Strategist with CrowdStrike. “HDOs must implement a modern, layered-defense strategy that continuously improves visibility, incorporates EDR, and includes containment capabilities so that they can accurately detect, respond and prevent sophisticated attacks.”

CrowdStrike and Medigate deliver an integrated solution that provides comprehensive visibility and strengthened protection for all managed and unmanaged devices in HDO environments.  Together, the companies are recharging existing HDO asset management and security infrastructure, creating a strong foundation for a layered defense.

To learn more about Medigate and CrowdStrike and access the research paper, click here: https://discover.medigate.io/medigate_crowdstrike_research

About Medigate

Medigate is the industry’s first and leading dedicated medical device security and asset management platform, enabling providers to deliver secure, connected care. Medigate fuses the knowledge and understanding of medical workflow and device identity and protocols with the reality of today’s cybersecurity threats. With Medigate, hospital networks can safely operate all medical devices on their network, enabling the deployment of existing and new devices to patients while ensuring privacy and safety. To date, Medigate has won more than 40 industry awards, including 2021 Best in KLAS for Healthcare IoT Security, the SINET Innovator Award, Fast Company’s Most Innovative Company Award, and has been identified as a leader in Forrester’s New Wave for Connected Medical Devices as well as listed in Forbes Top 20 IoT Start-Ups to Watch.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/82-percent-of-health-systems-reported-experiencing-an-iot-cyberattack-in-last-18-months-301425405.html

SOURCE Medigate

Staff

Recent Posts

Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics

GENEVA, SWITZERLAND / ACCESS Newswire / December 15, 2025 / MindMaze Therapeutics Holding SA (SIX:MMTX)…

2 hours ago

Vaxxas Secures TGA Licence to Manufacture Therapeutic Goods

Milestone enables GMP manufacturing to accelerate clinical trials and transform global vaccine delivery BRISBANE, Australia…

20 hours ago

InnoCare Announces Achievement of Primary Endpoint in Phase IIb Study of Orelabrutinib for SLE and Approval of Phase III Clinical Trial

BEIJING, Dec. 14, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading…

20 hours ago

President Trump’s Cannabis Decision Is Coming – And Why MMJ International Holdings Wins Either Way

12 Month Timeline - How Cannabis Rescheduling Actually Takes EffectAnnouncementPresident signals intent or issues executive…

2 days ago

Accelerating Patient Recruitment and Research Excellence: TrialWire® Supports Endpoints Clinical Trials Day NYC 2025

NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- TrialWire®, the industry’s fastest, intelligent patient recruitment…

2 days ago